LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

FDA may pull authorization of Pfizer’s Covid vaccine for children under 5, company says

Robert Frost by Robert Frost
August 12, 2025
in Industries
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5, company says
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois, Dec. 30, 2021.

Brian Cassella | Tribune News Service | Getty Images

The Food and Drug Administration is considering revoking its authorization of Pfizer‘s Covid-19 vaccine for healthy children under the age of 5, the drugmaker confirmed to CNBC on Tuesday. 

The move could leave many kids with no available shot against the virus, as jabs from Moderna and Novavax are cleared for more limited populations. While Covid typically causes mild symptoms in most children, others, such as infants under 1 or those with certain health conditions, can be at a higher risk of severe illness and hospitalization.

If the FDA pulls the authorization, it would add to a string of recent efforts by U.S. health agencies to change and undermine immunization policy since Health and Human Services Secretary Robert F. Kennedy Jr., a prominent vaccine skeptic, took the helm. HHS did not immediately respond to a request for comment.

You might also like

Sends shares Q1 2026 business update and product progress

BP flags ‘exceptional’ oil trading performance as Iran war chokes supply

Why the economy could be spared 2022-style inflation despite high oil prices

The FDA told Pfizer it might not renew its longstanding emergency use authorization for children ages 6 months to 4 years, the company said in a statement. Pfizer said it has requested the authorization to remain in place for the upcoming fall and winter season and is “currently in discussions with the agency on potential paths forward.”

The company said that the FDA’s “deliberations” are not related to the safety and efficacy of the shot, “which continues to demonstrate a favorable profile.”

The Guardian first reported on the FDA’s potential move. Moderna is working with the Centers for Disease Control and Prevention to boost supplies of its own Covid shot for children, the Guardian reported Saturday.

In July, the FDA granted full approval to Moderna’s Covid vaccine for children — but only for those with one more more health conditions that may put them at increased risk of severe illness if they become infected. The shots from both Moderna and Pfizer use messenger RNA technology.

Kennedy has targeted those vaccines in the past, filing a petition in May 2021 demanding that the agency revoke authorization of the jabs.  

Meanwhile, Novavax‘s protein-based shot has never been available for children under 12. 

In May, Kennedy announced that the Centers for Disease Control and Prevention has removed its recommendation of Covid vaccines for healthy children and pregnant women. 

But in updated guidance days later, the CDC said the shots “may” be given to those kids if a doctor agreed that it was necessary. Covid vaccines during pregnancy are now listed as “No Guidance/Not Applicable,” where they were previously recommended for all pregnant adults.

[ad_2]

Source link

Share30Tweet19
Previous Post

Ether futures open interest hits all-time high as ETH price tops $4.5K — Will it last?

Next Post

Pantera’s bear market Bitcoin call nails 2025 price, silencing cycle skeptics

Robert Frost

Robert Frost

Recommended For You

Sends shares Q1 2026 business update and product progress
Industries

Sends shares Q1 2026 business update and product progress

April 14, 2026
BP flags ‘exceptional’ oil trading performance as Iran war chokes supply
Industries

BP flags ‘exceptional’ oil trading performance as Iran war chokes supply

April 14, 2026
Why the economy could be spared 2022-style inflation despite high oil prices
Industries

Why the economy could be spared 2022-style inflation despite high oil prices

April 14, 2026
Europe cheers Orbán defeat as a bloody nose for the Kremlin – but Hungary’s future remains contested
Industries

Europe cheers Orbán defeat as a bloody nose for the Kremlin – but Hungary’s future remains contested

April 13, 2026
Next Post
Pantera’s bear market Bitcoin call nails 2025 price, silencing cycle skeptics

Pantera’s bear market Bitcoin call nails 2025 price, silencing cycle skeptics

Related News

U.S. stocks open higher as S&P 500, Nasdaq headed for fifth straight monthly gain

U.S. stocks open higher as S&P 500, Nasdaq headed for fifth straight monthly gain

July 31, 2023
Adding social media ‘is now essential to any estate agency’s marketing mix’ – London Wallet

Adding social media ‘is now essential to any estate agency’s marketing mix’ – London Wallet

May 7, 2025
Bricks over bytes: New hard asset ETF places big bet on real estate

Bricks over bytes: New hard asset ETF places big bet on real estate

June 24, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?